A Safety Study of IVMED-85 Ophthalmic Solution in Healthy Adults

Phase 1 Recruiting 36 enrolled iVeena Delivery Systems, Inc. Lexitas Pharma Services, Inc. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to determine the safety of IVMED-85 eye drops in healthy adult subjects. Participants will be assigned to either the active or vehicle eyedrop group. The participants will receive eye drops twice daily for 6 weeks. Participants will not know which eyedrop they are taking.

Timeline

Start: 2026-02-04
Primary completion: 2026-05
Completion: 2026-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IVMED-85	Unknown	0.2 mg/ml	Other

Indications

No indication recorded.